| Description | Ivuxolimab, an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody, targets a costimulatory receptor found on activated CD4+ and CD8+ T cells. It demonstrates antitumor properties and may exhibit immunostimulatory activity [1]. |
| molecular weight | N/A |
| CAS | 2128729-41-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |